Proceedings 2019Proceedings 2019
Menu

AIOC 2019, Indore

  • Home
  • Instruction Courses
  • Free Papers
  • E-Posters
  • Film Festival
  • Physical Posters
  • Poster Podium Presentations
  • Invited Sessions
  • Hyde Park
  • Pre-Conference Sessions
  • Communication

FP1727 : Subretinal fibrin as a clinical biomarker for CNV development

  1. Home
  2. /
  3. Physical Posters, Diabetic Retinopathy & Medical...
  4. /
  5. FP1727 : Subretinal fibrin...

FP1727 : Subretinal fibrin as a clinical biomarker for CNV development

Share this post

 

Dr.Muna Bhende, B10263

There is a continuous search for biomarkers that indicate the presence of CNV and predict response to therapy. We describe 4 eyes in which the significant clinical finding was subretinal fibrin and mild disturbance in vision . None showed CNV, PED , SRF or haemorrhage . OCT showed subretinal hyper reflectivity overlying a localised PED in 2 eyes and more extensive irregular RPE elevation in 2 eyes. All eyes had RPE disruption on OCT . In 2 eyes with suspected inflammatory lesions and localised RPE elevation, there was no CNV on angiography or OCT , but both developed drop in vision due to active CNV and subretinal hemorrhage less than a month later. In 2 eyes , ICG and OCTA showed type 1 CNV below the fibrin at the time of presentation. All eyes underwent treatment with intravitreal antiVEGF . The unexplained presence of subretinal fibrin can be a biomarker for the presence of, or indicator for development of CNV. Close followup and ICG and /or OCTA are warranted in these cases.

CLICK HERE TO VIEW THE POSTER

Share on FacebookShare on TwitterShare on Google+

Leave a Comment Cancel Reply

  • Home
  • Instruction Courses
  • Free Papers
  • E-Posters
  • Film Festival
  • Physical Posters
  • Poster Podium Presentations
  • Invited Sessions
  • Hyde Park
  • Pre-Conference Sessions
  • Communication
Close